Dr. Latha Kiran Krishna Rajendran

Redefining Oncology: From Reactive Care to Predictive Intelligence Through Digital Twins and Foundation AI Models

Abstract:

Oncology is undergoing a paradigm shift from reactive treatment to predictive, personalized care powered by digital twins and foundation AI models. By integrating multi-omics data, clinical histories, and real-time patient monitoring, digital twins enable dynamic simulation of disease progression and therapeutic response. Foundation models amplify this capability through scalable pattern recognition and decision support. Together, these technologies promise earlier interventions, optimized treatment strategies, and improved outcomes, redefining precision oncology into a proactive, continuously learning healthcare ecosystem.

Profile:

Dr. Latha Kiran Krishna Rajendran is a General Practitioner– Clinical Researcher, physician innovator, and emerging thought leader working at the convergence of oncology, artificial intelligence, predictive healthcare systems, and translational medical research. With a strong foundation in clinical medicine and extensive experience across emergency care, women’s health, chronic disease management, preventive healthcare, and hospital operations, she brings a uniquely multidisciplinary perspective that bridges frontline patient care with next-generation computational medicine.

Her research is centered on transforming modern oncology through intelligent, data-driven technologies capable of enabling earlier diagnosis, personalized therapeutic strategies, and predictive clinical decision-making. Her academic work explores advanced domains including foundation AI models, multimodal radiomics, digital twin frameworks, bioinformatics, explainable artificial intelligence, predictive disease modeling, precision oncology, and AI-driven drug repurposing systems. Through peer-reviewed scientific publications, conference collaborations, and translational healthcare research, she has contributed to the development of scalable and clinically interpretable AI solutions designed to improve cancer outcomes and optimize patient-centered care. 

In addition to her clinical and scientific contributions, Dr. Latha has actively participated in international academic activities as a peer reviewer, invited speaker, session chair, and contributor to interdisciplinary scientific initiatives focused on emerging healthcare technologies and precision medicine. Her work reflects a broader vision of shifting healthcare from reactive treatment models toward proactive, predictive, and precision-based systems powered by intelligent analytics and real-world clinical integration.
 
Driven by a commitment to innovation, translational impact, and evidence-based medicine, Dr. Latha continues to advance research that integrates oncology, computational intelligence, and digital health technologies to support the future of personalized cancer care and globally scalable healthcare innovation.